Peritoneal Dialysis Catheters Market Report Scope & Overview:

The Peritoneal Dialysis Catheters Market was valued at USD 1.11 Billion in 2025 and is expected to reach USD 2.26 Billion by 2035, growing at a CAGR of 7.36% from 2026-2035.

The Peritoneal Dialysis Catheters Market will see traction due to rising chronic kidney disease and end-stage renal disease prevalence, payment reforms favoring home dialysis, and growing adoption of urgent-start peritoneal dialysis. With the rise in value-based renal care programs in the U.S., along with the PD-first programs in Asia, patients are being moved from in-center hemodialysis to home dialysis treatments. With regard to catheters, there are advances in the form of anti-microbial coatings, weighted tips to prevent migration and sensors for detecting infections early. Home dialysis is also becoming economically viable through remote monitoring systems. Growth in nurse training programs and patient preference for home dialysis will continue to drive catheter demand.

In April 2026, Fresenius Medical Care began a 300-patient observational study at Klinikum Dortmund, Germany, evaluating the long-term safety and efficacy of its PD catheters in adult and pediatric patients. The study will analyze catheter performance, peritoneal clearance, and ultrafiltration outcomes through 2029.

Peritoneal Dialysis Catheters Market Trends:

• Rising shift from in-center hemodialysis to home-based peritoneal dialysis therapy.

• Growing adoption of weighted-tip and self-locating catheters to reduce malposition.

• Increasing use of antimicrobial-impregnated silicone to lower peritonitis risk.

• Expanding urgent-start PD protocols for patients with acute kidney injury.

• Growing integration of remote monitoring and sensor data with home PD programs.

• Rising PD-first policies in Asia-Pacific countries such as Thailand and China.

U.S. Peritoneal Dialysis Catheters Market Outlook:

The U.S. Peritoneal Dialysis Catheters Market was valued at USD 0.33 Billion in 2025 and is expected to reach USD 0.64 Billion by 2035, growing at a CAGR of 6.84% from 2026-2035.

The U.S. Peritoneal Dialysis Catheters Market is expanding owing to the large chronic kidney disease population, estimated at 35.5 million adults, and strong policy support for home dialysis. Medicare’s broad ESRD coverage, training add-on payments, and value-based programs such as Comprehensive Kidney Care Contracting encourage providers to place more patients on peritoneal dialysis. The 2025 expansion into patients with acute kidney injury led to a surge of thousands of patients for home dialysis every year. With home dialysis comprising about 14% of the market, there is definitely an area for growth and the continued need for catheters, insertion and other equipment. Increased awareness on the part of nephrologists also helps to facilitate referrals to peritoneal dialysis.

In January 2025, Vantive completed its separation from Baxter International, becoming a dedicated kidney care company with about USD 4.5 billion in annual revenue. The spinout allows Vantive to focus investment on peritoneal dialysis therapies, catheter portfolios, and remote monitoring platforms such as Sharesource for home dialysis patients.

Peritoneal Dialysis Catheters Market Segment Analysis:

• By Catheter Design, the Straight Tenckhoff Catheters segment dominated the Peritoneal Dialysis Catheters Market with approximately 55.42% share in 2025, while the Self-Locating/Weighted-Tip Catheters segment is the fastest growing with a CAGR of approximately 9.14%.

• By Material, the Medical-Grade Silicone segment dominated the Peritoneal Dialysis Catheters Market with approximately 69.31% share in 2025, while the Antimicrobial-Impregnated Silicone segment is the fastest growing with a CAGR of approximately 8.27%.

• By End User, the Hospitals segment dominated the Peritoneal Dialysis Catheters Market with approximately 45.68% share in 2025, while the Home-Care Settings segment is the fastest growing with a CAGR of approximately 10.06%.

By Catheter Design, Tenckhoff Leads, While Weighted-Tip Catheters Grow Fastest

The straight Tenckhoff catheters segment dominated the Peritoneal Dialysis Catheters Market in 2025, as this design has been the standard for peritoneal dialysis access for decades. Nephrologists and surgeons are highly familiar with its placement, and it offers reliable long-term performance at a relatively low cost. Straight Tenckhoff catheters are available from many manufacturers in single-cuff and double-cuff versions, making them widely accessible across hospitals and dialysis centers. Their broad clinical evidence base and simple insertion techniques continue to support strong use in both developed markets and cost-sensitive emerging economies. Many centers also prefer this design for urgent-start PD placements.

Self-locating and weighted-tip catheters are the fastest-growing design, as they reduce catheter migration and malposition, which are common causes of poor drainage and catheter failure. European trials showed that weighted-tip designs cut malposition rates from about 12% to 4%, lowering the need for repositioning procedures. These benefits reduce hospitalizations and help maintain patients on home therapy. Although these catheters carry price premiums of 20% to 30%, payers that reward fewer complications are encouraging adoption. Tightening infection and technique-survival targets are expected to further accelerate demand for these advanced designs. Wider clinical evidence will also support broader payer coverage and adoption.

By Material, Silicone Leads, While Antimicrobial Silicone Grows Fastest

Medical-grade silicone emerged as the dominant material in the Peritoneal Dialysis Catheters Market in 2025, attributed to its excellent biocompatibility, flexibility, and anti-kinking properties ideal for long-term implantation. Silicone catheters are known to trigger minimal tissue reaction and remain comfortable for the patients throughout the time of use. Standard tenkoff, coiled, and swan neck catheters are usually made of silicone due to their mature manufacturing process and regulation. However, raw silicone prices have increased by about 12% in comparison with 2023 because of supply shortages in China. In spite of the above challenge, the material continues to be preferred for most catheters. Hybrid materials emerge as alternatives for certain patient segments.

Antimicrobial-impregnated silicone has become the fastest-growing material as peritonitis and exit-site infections continue to be major causes of technique failure and hospitalization. According to a European trial held in 2025, silver nanoparticle silicone catheters have managed to reduce biofilm formation by 68% and exit site infections by 32% in comparison with uncoated devices. Payers are increasingly fining providers for infection-related admissions, compelling them to use catheters minimizing such risks. Silver ions, chlorhexidine, and antibiotics coatings each have their advantages and disadvantages. Manufacturers, which are capable of reducing the total cost of care for payers through reduction in infections, are expected to grow well.

By End User, Hospitals Lead, While Home-Care Settings Grow Fastest

The hospitals segment dominated the Peritoneal Dialysis Catheters Market in 2025, as most catheter insertions are performed in hospital operating rooms, interventional radiology suites, or bedside settings. Hospitals also manage complications such as catheter malfunction, peritonitis, leaks, and hernias, which may require catheter repositioning or replacement. Urgent-start peritoneal dialysis for patients with acute kidney injury is typically initiated in hospitals, increasing catheter use. Large hospital systems have the surgical teams, imaging, and nephrology expertise needed for complex placements, supporting the segment’s leading share throughout the forecast period. Hospital-based training programs also support patient transition to home therapy over time across major markets.

Home-care settings are the fastest-growing end user segment, driven by strong policy and reimbursement support for home dialysis in the United States, Canada, Australia, and parts of Asia. Patients increasingly prefer home therapy for its flexibility, independence, and reduced travel to dialysis centers. Remote monitoring platforms, such as Baxter’s Claria with Sharesource, have reduced hospitalizations in clinical studies, strengthening the case for home care. Nurse-led training programs are helping more patients manage dialysis safely at home. As home penetration rises, demand for catheters and related supplies in this setting is expected to grow rapidly. Patient support services further improve outcomes.

Regional Analysis:

North America Peritoneal Dialysis Catheters Market Insights

North America accounted for approximately 34.62% of the Peritoneal Dialysis Catheters Market in 2025, the largest share among all regions, supported by Medicare’s broad ESRD coverage, value-based kidney care programs, and strong policy support for home dialysis. The United States generates most regional revenue, with home dialysis penetration of about 14% leaving substantial room for growth. Leading companies such as Vantive, Fresenius Medical Care, Medtronic, and Merit Medical maintain strong positions. Commercial insurers have also introduced bundled payment programs that cover catheter insertion, training, and supplies, simplifying home dialysis initiation. Strong policy momentum continues to support adoption across the region.

Canada is becoming increasingly active, with Ontario and British Columbia increasing the per-diem support of home peritoneal dialysis by 12% in 2025. The increase allows the program to employ specialists in home dialysis nursing. Mexico is experiencing growth in the market because peritoneal dialysis is commonly practiced due to its cost benefits and the lack of facilities for hemodialysis in certain regions. In the U.S., Medicare Advantage plans accounting for more than half of the beneficiaries in 2025 started to include home dialysis initiation in their quality standards. However, the problems related to the increased risk of peritonitis and ongoing patient education still impact the choice of modality in the region. Remote monitoring has become the solution for some of these clinical issues.

Europe Peritoneal Dialysis Catheters Market Insights

Europe continues to be a major regional market, supported by Germany, the UK, France, Italy, and Spain, where established nephrology services and public healthcare systems provide broad access to dialysis. Peritoneal dialysis use varies widely across the region, from about 2% of dialysis patients in Romania to around 22% in the Netherlands, reflecting differences in staffing, reimbursement, and clinical practice. Leading manufacturers such as Fresenius Medical Care and B. Braun are headquartered in Germany. European clinical research on antimicrobial and weighted-tip catheters is also supporting innovation and evidence-based product adoption. National registries further support quality improvement efforts across the region.

Germany is the leader in the regional market due to the reimbursement of peritoneal dialysis equal to hemodialysis and the existence of a network of nephrology centers. The NHS in the UK promotes the use of home dialysis to reduce the burden on dialysis units, which supports the need for catheters. France, Italy, and Spain offer stable growth thanks to hospital-based PD programs and increasing interest in home treatments. The Netherlands and Nordic countries have one of the highest rates of PD use in Europe. However, the shortage of nurses and different levels of reimbursement in some countries inhibit the further development of PD in the region.

Asia-Pacific Peritoneal Dialysis Catheters Market Insights

Asia-Pacific is currently witnessing the highest growth rate in the Peritoneal Dialysis Catheters Market, anticipated to record a CAGR of around 9.47% during the forecast period from 2026 to 2035, due to the rapid rise of chronic kidney disease linked to diabetes and hypertension and supportive government policies. China is the largest market in the region, supported by the 2024 inclusion of PD supplies in the essential medicines list and requirements for tertiary hospitals to train dedicated PD nurses. These policies are expected to significantly increase peritoneal dialysis prevalence across the country. Rising urban CKD rates also drive strong catheter demand.

Thailand’s PD-First policy has kept peritoneal dialysis use above 50% among incident patients in public hospitals, making it a regional leader. India is emerging as a key growth market, driven by a large and growing CKD population and urban patients seeking flexible home therapy, although the country has only about 0.9 nephrologists per million people. Japan, South Korea, and Australia have advanced dialysis systems, with Australia’s home dialysis penetration exceeding 30%. Local manufacturers such as Nipro, Terumo, Asahi Kasei, and WEGO are expanding production to meet rising regional demand. Training programs are also expanding rapidly across the wider Asia-Pacific region.

MEA & Latin America Peritoneal Dialysis Catheters Market Insights

The Middle East & Africa region represents a smaller but growing share of the Peritoneal Dialysis Catheters Market, led by Gulf Cooperation Council states such as Saudi Arabia and the UAE, where high diabetes rates are increasing kidney disease prevalence. Government investments in specialty hospitals and dialysis centers are improving access to renal replacement therapies. Peritoneal dialysis offers advantages for patients in remote areas who live far from hemodialysis centers. However, nephrologist shortages are severe across much of Africa, where only a limited number of countries have adequate specialists, restricting broader adoption of PD. Regional training initiatives may gradually help improve access.

The development trend of Latin America is expected to be continuous; however, Brazil is leading the pack by virtue of its large number of CKD sufferers, healthcare services for the general public, and presence of dialysis services. Mobile simulation training units aimed at enhancing peritoneal dialysis skills were introduced in Brazil in 2025. Such training efforts, however, target mostly large cities such as São Paulo and Rio de Janeiro. Peritoneal dialysis is used widely in Latin America, with Mexico having the largest proportion of PD use. Colombia and Argentina play a part due to their private dialysis services. Nevertheless, financial constraints, inadequate training facilities, and high costs remain barriers to quick market growth.

Market Dynamics:

Growth Drivers: Rising CKD Prevalence and Home Dialysis Adoption

Factors influencing the growth of the Peritoneal Dialysis Catheters Market include the increasing prevalence of chronic kidney disease and end-stage renal disease. According to the statistics provided, in the United States, 35.5 million adults suffer from chronic kidney diseases, which is 14% of the country's population. The incidence of ESRD continues to rise as survival improves. In India and China, poorly managed diabetes and hypertension are responsible for over 60% of newly diagnosed ESRD cases among urban people. Aging populations and the growing trend towards obesity are expected to make more patients turn to dialysis. Besides, early diagnosis results in an increase in the number of dialysis candidates.

Another factor influencing the growth is the trend towards home dialysis. Peritoneal dialysis provides more freedom and is cheaper for patients compared to hemodialysis done at a specialized center. In 2025, CMS in the USA made provisions for training add-on payments and extended coverage for patients suffering from acute kidney injury. This makes these patients eligible for home dialysis. A value-based strategy called Comprehensive Kidney Care Contracting provides incentives to the providers for expanding the use of home dialysis. Some examples of the policies supporting the expansion of the use of peritoneal dialysis include the PD-First policy used in Thailand and the addition of PD products to essential medicines in China.

Restraints: Infection Risk and Limited Training Infrastructure

The high risk of peritonitis and catheter-related infections remains a key factor limiting market growth. Peritonitis causes 25% to 35% of peritoneal dialysis technique failures and costs between USD 5,000 and USD 8,000 per episode. Median U.S. peritonitis rates of about 0.48 episodes per patient-year remain above the International Society for Peritoneal Dialysis target of 0.4. Exit-site infections affect 15% to 20% of patients each year. In rural India, peritonitis rates are about twice as high as in urban centers due to water quality and limited follow-up care. These risks can reduce physician and patient confidence in home PD therapy overall.

Inadequate training infrastructure in emerging nations is yet another barrier because peritoneal dialysis requires trained nephrologists, surgeons, and nurses to insert the catheters as well as train the patients. India, for example, has only around 1,200 nephrologists for 1.4 billion people, and less than 500 trained PD nurses. In Sub-Saharan Africa, many nations do not have many nephrologists at all. This means that there will be high complication rates and low patient confidence. For the manufacturer, there will be a need for investment in train-the-trainer programs and simple insertion kits, hence increased costs. There is price volatility of silicone raw material and concentrated supply in China.

Opportunities: Advanced Catheter Designs and Emerging Market Expansion

There is a large potential in the development of advanced catheters. Antimicrobial coatings, weighted tips, and built-in sensors can decrease the rate of infections, malposition, and technique failure. With the help of catheters equipped with sensors, it is possible to detect peritonitis remotely, which increases the value of data and analysis over hardware. Specialized pediatric catheters and catheters for diabetic patients can meet significant demands. The companies which manage to show their products as those which have a lower total cost of care due to fewer hospitalizations will be able to get higher prices and contracts from value-based providers, insurers, and dialysis organizations.

At the same time, the fast development of chronic kidney disease in Asia-Pacific, Latin America, and Middle East provides an excellent growth opportunity. Peritoneal dialysis can be more affordable and available than hemodialysis in the countries with insufficient dialysis center capacity. This type of treatment is appealing for the governments which want to provide the cheapest solution to kidney diseases. PD-first strategy, essential medicines list, and national training programs increase the number of patients. The manufacturers which offer cheap catheters, efficient insertion kits, and training will be able to benefit from this growth.

Recent Developments:

• 2025, Simergent received FDA 510(k) clearance (K250523) for its Archimedes Pro Automated Peritoneal Dialysis Cycler, expanding home peritoneal dialysis equipment options.

• 2025, Ontario and British Columbia increased per-diem home peritoneal dialysis funding by 12%, enabling programs to hire dedicated home dialysis nurses.

• 2024, China included peritoneal dialysis supplies in its essential medicines list, supporting wider access to PD catheters and home therapy nationwide.

Peritoneal Dialysis Catheters Market Key Players:

• Vantive

• Fresenius Medical Care AG

• Medtronic plc

• B. Braun SE

• Terumo Corporation

• Nipro Corporation

• Cook Medical

• Merit Medical Systems, Inc.

• Medical Components, Inc. (Medcomp)

• Poly Medicure Ltd.

• WEGO Healthcare

• Utah Medical Products, Inc.

• Asahi Kasei Medical Co., Ltd.

• Nikkiso Co., Ltd.

• Toray Industries, Inc.

• Huaren Pharmaceutical Co., Ltd.

• Becton, Dickinson and Company (BD)

• Teleflex Incorporated

• Simergent, LLC

• CloudCath, Inc.

Peritoneal Dialysis Catheters Market Report Scope: